| 2024-06-04 | Sale | Myriad Genetics, Inc. MYGN | director | 3,788 0.0041% | $22.05 | $83,525 | +4.86% | |
| 2024-06-03 | Sale | Myriad Genetics, Inc. MYGN | director | 3,788 0.0041% | $22.04 | $83,488 | +4.11% | |
| 2023-06-02 | Sale | Myriad Genetics, Inc. MYGN | director | 8,638 0.0104% | $23.01 | $198,760 | -13.7% | |
| 2022-06-06 | Sale | Myriad Genetics, Inc. MYGN | 6,424 0.0082% | $19.25 | $123,673 | +7.21% | ||
| 2021-06-17 | Sale | Myriad Genetics, Inc. MYGN | director | 3,139 0.004% | $30.52 | $95,795 | -12.26% | |
| 2021-05-28 | Sale | Myriad Genetics, Inc. MYGN | director | 7,142 0.0094% | $28.99 | $207,023 | -3.89% | |
| 2019-04-01 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 26,946 0.015% | $89.00 | $2.4M | -7.96% | |
| 2019-03-27 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 200 0.0001% | $90.00 | $18,000 | -6.4% | |
| 2018-06-22 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 20,000 0.0113% | $99.00 | $1.98M | -5.19% | |
| 2018-04-23 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 22,118 0.0125% | $82.15 | $1.82M | +14.77% | |
| 2017-03-16 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 3,978 0.0023% | $91.96 | $365,817 | -2.01% | |
| 2017-03-06 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 4,606 0.0027% | $93.32 | $429,832 | -2.56% | |
| 2017-03-01 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 10,000 0.0058% | $94.50 | $945,000 | -4.47% | |
| 2017-02-28 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 60,000 0.0291% | $78.55 | $4.71M | -4.57% | |
| 2017-01-09 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 10,000 0.0057% | $90.00 | $900,000 | -1.58% | |
| 2016-11-09 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 40,000 0.0229% | $90.61 | $3.62M | -2.8% | |
| 2016-08-01 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 8,000 0.0047% | $99.33 | $794,640 | -10.23% | |
| 2016-06-06 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 3,298 0.002% | $89.14 | $293,984 | -0.18% | |
| 2016-05-31 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 41,682 0.0198% | $69.23 | $2.89M | -0.39% | |
| 2016-05-23 | Sale | BioMarin Pharmaceutical Inc. BMRN | EVP, Chief Financial Officer | 7,538 0.0047% | $87.07 | $656,368 | +4.5% |